HCA
IBB icon

Heck Capital Advisors’s iShares Biotechnology ETF IBB Stock Holding History

Heck Capital Advisors’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-58
Closed -$7.67K – 493
2024
Q4 		$7.67K Buy
+58
New +$8.15K ﹤0.01% 549

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return
MMEA
Main Management ETF Advisors San Francisco, California $3.3B AUM 33.88% 1-Year Est. Return

Heck Capital Advisors's IBB Position: Q1 2025 in Review

Heck Capital Advisors sold out of iShares Biotechnology ETF (IBB) in Q1 2025, closing a stake of 58 shares — an estimated $7.67K sold.

Heck Capital Advisors first reported a position in IBB in Q4 2024 and held it in 1 quarter. The position peaked at $7.67K in Q4 2024. 835 funds tracked by Wall St. Rank hold IBB as of Q1 2025.

  • Heck Capital Advisors reported no remaining iShares Biotechnology ETF position as of Q1 2025 after selling out during the quarter.
  • Heck Capital Advisors sold 58 iShares Biotechnology ETF shares in Q1 2025, an estimated $7.67K.
  • Heck Capital Advisors first reported a position in iShares Biotechnology ETF in Q4 2024 and held it in 1 quarter.
  • Heck Capital Advisors's iShares Biotechnology ETF position peaked at $7.67K in Q4 2024.
  • 835 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2025.

Based on Heck Capital Advisors's 13F filing for Q1 2025, filed 13 May 2025.